Common Contracts
2 similar Securities Purchase Agreement contracts by Chromocell Therapeutics Corp
FIRST AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTESecurities Purchase Agreement • October 25th, 2023 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances)
This First Amendment to Senior Secured Convertible Note (this “Amendment”) dated as of October 12, 2023 (the “Effective Date”) is entered into by and between Chromocell Therapeutics Corporation, a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, a “Purchaser” and together, the “Purchasers”).
FIRST AMENDMENT TO SENIOR SECURED CONVERTIBLE NOTESecurities Purchase Agreement • October 16th, 2023 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances)
This First Amendment to Senior Secured Convertible Note (this “Amendment”) dated as of October 12, 2023 (the “Effective Date”) is entered into by and between Chromocell Therapeutics Corporation, a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, a “Purchaser” and together, the “Purchasers”).
